These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7594060)

  • 41. Primary results of COPERNICUS, a pivotal landmark study (Carvedilol Prospective Randomised Cumulative Survival Trial).
    Cardiovasc J S Afr; 2001; 12(1):57. PubMed ID: 11474691
    [No Abstract]   [Full Text] [Related]  

  • 42. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure.
    Fowler MB
    Am J Cardiol; 2004 May; 93(9A):35B-9B. PubMed ID: 15144935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 45. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter by Lowenthal et al regarding article, "BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial".
    Lowenthal A; Shah A; Bernstein HS
    Circ Heart Fail; 2010 Nov; 3(6):e32; author reply e33. PubMed ID: 21081737
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacogenetics and heart failure: a convergence with carvedilol.
    Meadowcroft AM; Williamson KM; Patterson JH; Pieper JA
    Pharmacotherapy; 1997; 17(4):637-9. PubMed ID: 9250542
    [No Abstract]   [Full Text] [Related]  

  • 48. A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide.
    Kobayakawa N; Sawaki D; Otani Y; Sekita G; Fukushima K; Takeuchi H; Aoyagi T
    Cardiovasc Drugs Ther; 2003 May; 17(3):295. PubMed ID: 14669748
    [No Abstract]   [Full Text] [Related]  

  • 49. Blood pressure and the therapy of advanced heart failure.
    Cohn JN
    J Am Coll Cardiol; 2004 Apr; 43(8):1430-1. PubMed ID: 15093879
    [No Abstract]   [Full Text] [Related]  

  • 50. Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.
    de Boer RA; Siebelink HJ; Tio RA; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2001 Jun; 3(3):331-3. PubMed ID: 11378004
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical efficacy of carvedilol in patients with severe cardiac insufficiency].
    Sitnikova MIu; Bol'shakova OO; Brodskaia IS; Kozlova SN; Krutikov AN; Shliakhto EV
    Ter Arkh; 2001; 73(1):46-9. PubMed ID: 11234141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta blocker benefits patients with advanced heart failure.
    Geriatrics; 2000 Nov; 55(11):18, 21. PubMed ID: 11086468
    [No Abstract]   [Full Text] [Related]  

  • 53. [Place of beta blockaders in the treatment of heart failure].
    Pornin M; Van Viet H
    Ann Cardiol Angeiol (Paris); 1998 Dec; 47(10):753-6. PubMed ID: 9922855
    [No Abstract]   [Full Text] [Related]  

  • 54. Beta-blockers in chronic heart failure.
    Stoschitzky K
    Eur Heart J; 2002 Mar; 23(5):426; author reply 426-7. PubMed ID: 11846503
    [No Abstract]   [Full Text] [Related]  

  • 55. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [COPD patients with heart failure: no concern about the beta blocker!].
    Stiefelhagen P
    MMW Fortschr Med; 2012 Apr; 154(6):26. PubMed ID: 22642023
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of carvedilol in daily practice].
    Cohen-Solal A; Logeart D; Guiti C; Bourgoin P
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):647-51. PubMed ID: 12555472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
    MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
    [No Abstract]   [Full Text] [Related]  

  • 59. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heart failure patients with B1-adrenoreceptor polymorphisms have augmented carvedilol response as detected by cardiac I123-MIBG scintigraphy.
    Miranda SM; Moscavitch SD; Pereira SB; de Azevedo JC; Messias LR; Rodrigues RC; Mesquita ET; Ribeiro GS; Mesquita CT
    Int J Cardiol; 2014 Nov; 177(1):111-3. PubMed ID: 25499350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.